These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 8443869

  • 1. Intense sympathetic stimulation releases neuropeptide Y but fails to evoke sustained coronary vasoconstriction in dogs.
    Otani N, Yang T, Levy MN.
    Circ Res; 1993 Apr; 72(4):816-26. PubMed ID: 8443869
    [Abstract] [Full Text] [Related]

  • 2. Effects of intense antecedent sympathetic stimulation on sympathetic neurotransmission in the heart.
    Yang T, Levy MN.
    Circ Res; 1993 Jan; 72(1):137-44. PubMed ID: 8380260
    [Abstract] [Full Text] [Related]

  • 3. Inhibitory effects of nicorandil on sympathetic coronary vasoconstriction.
    Chujo M, Mori H, Tanaka E, Nakazawa H, Okino H.
    Cardiovasc Res; 1994 Jun; 28(6):917-22. PubMed ID: 7923299
    [Abstract] [Full Text] [Related]

  • 4. Coronary vasoconstrictive effects of neuropeptide Y and their modulation by the ATP-sensitive potassium channel in anesthetized dogs.
    Tanaka E, Mori H, Chujo M, Yamakawa A, Mohammed MU, Shinozaki Y, Tobita K, Sekka T, Ito K, Nakazawa H.
    J Am Coll Cardiol; 1997 May; 29(6):1380-9. PubMed ID: 9137239
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of cardiac vagal effects by neurally released and exogenous neuropeptide Y.
    Warner MR, Levy MN.
    Circ Res; 1989 Dec; 65(6):1536-46. PubMed ID: 2582589
    [Abstract] [Full Text] [Related]

  • 6. The effects of neuropeptide Y on myocardial contractility and coronary blood flow.
    Awad SJ, Einstein R, Potter EK, Richardson DP.
    Br J Pharmacol; 1991 Sep; 104(1):195-201. PubMed ID: 1838493
    [Abstract] [Full Text] [Related]

  • 7. Attenuation of long-lasting effects of sympathetic stimulation after repeated stimulation.
    Hall GT, Gardner TD, Potter EK.
    Circ Res; 1990 Jul; 67(1):193-8. PubMed ID: 2364490
    [Abstract] [Full Text] [Related]

  • 8. Direct evidence for the role of neuropeptide Y in sympathetic nerve stimulation-induced vasoconstriction.
    Han S, Yang CL, Chen X, Naes L, Cox BF, Westfall T.
    Am J Physiol; 1998 Jan; 274(1):H290-4. PubMed ID: 9458879
    [Abstract] [Full Text] [Related]

  • 9. Potency and receptors involved in coronary vasoconstriction caused by neuropeptide Y(NPY).
    Aizawa Y, Satoh M, Aizawa M, Funazaki T, Niwano S, Miyajima S, Shibata A.
    Jpn Heart J; 1987 Nov; 28(6):891-8. PubMed ID: 2832630
    [Abstract] [Full Text] [Related]

  • 10. Neuropeptide Y and control of vascular resistance in skeletal muscle.
    Revington M, McCloskey DI.
    Regul Pept; 1988 Dec; 23(3):331-42. PubMed ID: 3238054
    [Abstract] [Full Text] [Related]

  • 11. Neuropeptide Y and differential sympathetic control of splenic blood flow and capacitance function in the pig and dog.
    Modin A, Pernow J, Lundberg JM.
    Acta Physiol Scand; 1993 Jan; 147(1):15-25. PubMed ID: 8095766
    [Abstract] [Full Text] [Related]

  • 12. Differential action of hepatic sympathetic neuropeptides: metabolic action of galanin, vascular action of NPY.
    Mundinger TO, Taborsky GJ.
    Am J Physiol Endocrinol Metab; 2000 Mar; 278(3):E390-7. PubMed ID: 10710492
    [Abstract] [Full Text] [Related]

  • 13. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
    Modin A.
    Acta Physiol Scand Suppl; 1994 Mar; 622():1-74. PubMed ID: 7524267
    [Abstract] [Full Text] [Related]

  • 14. Influence of sympathetic discharge pattern on norepinephrine and neuropeptide Y release.
    Pernow J, Schwieler J, Kahan T, Hjemdahl P, Oberle J, Wallin BG, Lundberg JM.
    Am J Physiol; 1989 Sep; 257(3 Pt 2):H866-72. PubMed ID: 2782443
    [Abstract] [Full Text] [Related]

  • 15. D-myo-inositol-1,2,6-triphosphate (PP56) antagonizes nonadrenergic sympathetic vasoconstriction: possible involvement of neuropeptide Y.
    Schwieler JH, Hjemdahl P.
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):347-52. PubMed ID: 7681493
    [Abstract] [Full Text] [Related]

  • 16. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
    Pernow J, Kahan T, Hjemdahl P, Lundberg JM.
    Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
    [Abstract] [Full Text] [Related]

  • 17. Neuropeptide Y and reserpine-resistant vasoconstriction evoked by sympathetic nerve stimulation in the dog skeletal muscle.
    Pernow J, Kahan T, Lundberg JM.
    Br J Pharmacol; 1988 Jul; 94(3):952-60. PubMed ID: 3179619
    [Abstract] [Full Text] [Related]

  • 18. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
    Pernow J, Lundberg JM.
    Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
    Lundberg JM, Modin A.
    Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
    [Abstract] [Full Text] [Related]

  • 20. Sympathetic thyroidal vasoconstriction is not blocked by a neuropeptide Y antagonist or antiserum.
    Dey M, Michalkiewicz M, Huffman L, Hedge GA.
    Peptides; 1993 Dec; 14(6):1179-86. PubMed ID: 8134299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.